Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Direct Selective Laser Trabeculoplasty (DSLT): Accessible glaucoma care in seconds

Project description

Laser treatment for glaucoma

Glaucoma is an eye disease caused by damage to the optic nerve and unless treated, it can cause vision loss. Funded by the European Innovation Council, the EyeAccess project is introducing a novel laser treatment for glaucoma. The Eagle™ device is automated, easy to use and can be operated by non-expert personnel, making it accessible to more doctors as a first-line treatment for glaucoma patients. Moreover, the Eagle device, which is CE marked, is a patient-friendly, simple and non-contact procedure which will guarantee patient compliance and expedited application in more patients.

Objective

Our novel laser technology - Direct Selective Laser Trabeculoplasty (DSLT) is an automated laser procedure for accessible primary treatment of glaucoma and ocular hypertension. Our Eagle device has the potential to revolutionize glaucoma care as it is non-contact, intuitive, and quick.
The technology is ground-breaking, as the procedure doesnt require expertise and involves simply pressing a button and delivering treatment in seconds. DSLT technology is poised to achieve widespread acceptance, as it is not limited to glaucoma specialists, or bound to glaucoma medication
compliance. In addition, our technology is supported by promising First-in-Human clinical trial results as well as the expertise and guidance of key opinion leaders in the field of ophthalmology. EIC funding will support BELKIN Laser (re-branded recently as BELKIN Vision) in commercializing
this sight-saving technology by establishing the commercial value chain, market launch, and scale-up.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2021-ACCELERATOROPEN-01

See all projects funded under this call

Coordinator

BELKIN VISION LTD
Net EU contribution
€ 2 500 000,00
Address
13 GAN RAVE BOULEVARD 3RD FLOOR
8122214 Yavne
Israel
SME
Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 6 589 750,00